0 NASDAQ Companies - May 3, 2024Augmedix to Participate in Upcoming Investor Conferences in May and June 2024SAN FRANCISCO, May 03, 2024 (GLOBE NEWSWIRE) — Augmedix, Inc. (Nasdaq: AUGX), a leader in ambient AI medical documentation and […]Read More
0 NASDAQ Companies - May 3, 2024BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED TherapeuticsFLORHAM PARK, N.J., May 03, 2024 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global […]Read More
0 NASDAQ Companies - May 3, 2024Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024CAMBRIDGE, Mass., May 03, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK […]Read More
0 NASDAQ Companies - May 3, 2024Balchem Corporation Reports First Quarter 2024 Financial ResultsMONTVALE, N.J., May 03, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal […]Read More
0 NASDAQ Companies - May 3, 2024Werewolf Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update— Company to present an update of its ongoing monotherapy and combination Phase 1/1b trial of WTX-124 in advanced or […]Read More
0 NASDAQ Companies - May 3, 2024ECARX Releases Multiple Intelligent Driving Features for Skyland ProSHANGHAI, China, May 03, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility […]Read More
0 NASDAQ Companies - May 3, 2024Aveanna to Participate at the Barclays Leveraged Finance ConferenceATLANTA, May 03, 2024 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team […]Read More
0 NASDAQ Companies - May 3, 2024Immuron Director ResignationMELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated […]Read More
0 NASDAQ Companies - May 2, 2024Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common StockREDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical […]Read More
0 NASDAQ Companies - May 2, 2024Silicon Motion Announces Results for the Period Ended March 31, 2024Business Highlights First quarter of 2024 sales decreased 6% Q/Q and increased 53% Y/Y SSD controller sales: 1Q of 2024 […]Read More